Instil Bio, Inc. (TIL)
NCM · Healthcare · Biotechnology
$7.22
-0.96%
Closing price as of 2026-07-29 · Source: TEK2day Finance
Key Metrics
Market Cap
$49.0M
Shares Outstanding
6.8M
Exchange
NCM
Currency
USD
About Instil Bio, Inc.
Instil Bio, Inc., a biopharmaceutical company, focuses on identifying and advancing therapeutic opportunities. It seeks to in-license or acquire and develop additional novel therapeutic candidates in diseases with significant unmet medical need. Instil Bio, Inc. was incorporated in 2018 and is headquartered in Dallas, Texas.
Quarterly Financials
| Metric | 2025-06-30 | 2025-09-30 | 2025-12-31 | 2026-03-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -12.9M | -15.0M | -9.6M | -6.0M |
| Net Income | -21.4M | -13.6M | -8.2M | -4.2M |
| Diluted EPS | $-3.24 | $-2.01 | $nan | $-0.62 |
Annual Financials
| Metric | 2022-12-31 | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Income | -203.3M | -87.2M | -56.0M | -52.0M |
| Net Income | -223.2M | -156.1M | -74.1M | -71.4M |
| Diluted EPS | $-34.40 | $-24.00 | $-11.39 | $-10.70 |